High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection

Transplantation

Volumn 65, Issue 6, 1998, Pages 826-831

  Cowan, Peter J ^a   Somerville, Christine A ^a   Shinkel, Trixie A ^a   Katerelos, Marina ^a   Aminian, Atousa ^a   Romanella, Margarita ^a   Tange, Margaret J ^a   Pearse, Martin J ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ENDOTHELIUM CELL; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TRANSGENIC MOUSE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD59; COMPLEMENT C3C; COMPLEMENT C9; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PERFUSION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032571230     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803270-00010     Document Type: Article

References (32)

1. Weill BJ, Regimbeau JM, Calmus Y, Chereau C, Houssin D. The alternative complement pathway in hyperacute xenograft rejection. Xeno 1994; 2: 92.
2. Kroshus TJ, Bolman RM, Dalmasso AP, et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61: 1513.
3. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
4. Johnston PS, Wang M-W, Lim SML, Wright LJ, White DJG. Discordant xenograft rejection in an antibody-free model. Transplantation 1992; 54: 573.
5. Romanella M, Aminian A, Adam WR, Pearse MJ, d'Apice AJF. Involvement of both the classical and alternate pathways of complement in an ex vivo model of xenograft rejection. Transplantation 1997; 63: 1021.
6. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
7. Parker W, Saadi S, Lin SS, Holzknecht ZE, Bustos M, Platt JL. Transplantation of discordant xenografts: a challenge revisited. Immunol Today 1996; 17: 373.
8. Brauer RB, Baldwin WM, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993; 151: 7240.
9. Zhow XJ, Niesen N, Pawlowski I, et al. Prolongation of survival of discordant kidney xenografts by C6 deficiency. Transplantation 1990; 50: 896.
10. Evans MJ, Rollins SA, Wolff DW, et al. In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5. Mol Immunol 1995; 32: 1183.
11. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61: 1241.
12. Oglesby TJ, Allen CJ, Liszewski MK, White DJG, Atkinson JP. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 1992; 175: 1547.
13. Loveland BE, Johnstone RW, Russell SM, Thorley BR, McKenzie IFC. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement-mediated lysis. Transplant Immunol 1993; 1: 101.
14. Carrington CA, Richards AC, Cozzi E, Langford G, Yannoutsos N, White DJG. Expression of human DAF and MCP on pig endothelial cells protects from human complement. Transplant Proc 1995; 27: 321.
15. Somerville CA, Kyriazis AG, McKenzie A, Allison J, Pearse MJ, d'Apice AJF. Functional expression of human CD59 in transgenic mice. Transplantation 1994; 58: 1430.
16. Rollins SA, Zhao J, Ninomiya H, Sims PJ. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunol 1991; 146: 2345.
17. Cowan PJ, Shinkel TA, Witort EJ, Barlow H, Pearse MJ, d'Apice AJF. Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter. Transplantation 1996; 62: 155.
18. Van Denderen BJW, Pearse MJ, Nottle MB, et al. Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack. Transplantation 1996; 61: 582.
19. Harrison RA, Lachman PJ. Handbook of experimental immunology and immunochemistry. Oxford: Blackwell Scientific Publications, 1986.
20. White DJG, Langford GA, Cozzi E, Young VK. Production of pigs transgenic for human DAF: a strategy for xenotransplantation. Xenotransplantation 1995; 2: 213.
21. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153.
22. McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. Transplantation 1995; 59: 1177.
23. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
24. Diamond LE, McCurry KR, Oldham ER, et al. Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement. Transplant Immunol 1995; 3: 305.
25. Yannoutsos N, Ijzermans JNM, White D, Grosveld F. Using yeast artificial chromosomes to generate transgenic animals. Xeno 1995; 3: 107.
26. Brooimans RA, van der Ark AAJ, Tomita M, van Es LA, Daha MR. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. Eur J Immunol 1992; 22: 791.
27. Asch A, Kinoshita T, Jaffe EA, Nussenzweig V. Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J Exp Med 1986; 163: 221.
28. Kennedy SP, Rollins SA, Burton WV, et al. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Transplantation 1994; 57: 1494.
29. Marquet RL, van Stijn I, van den Tol PM, Bonthuis F, Yannoutsos N, Ijzermans JNM. Human CD46 but not CD59 in transgenic mice protects against hyperacute rejection evoked by ex vivo perfusion with human serum. Transplant Proc 1997; 29: 931.
30. Dalmasso AP. Role of complement in xenograft rejection. In: Cooper DKC, Kemp E, Platt JL, White DJG, eds. Xenotransplantation. Berlin: Springer-Verlag, 1997: 38.
31. Waterworth PD, Cozzi E, Tolan MJ, et al. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transplant Proc 1997; 29: 899.
32. Tange MJ, Salvaris E, Romanella M, et al. Additive effects of CD59 expression in Gal knockout mice in vitro but not in an ex vivo model. Xenotransplantation 1997; 4: 25.